Breaking News Instant updates and real-time market news.

STE

Steris

$140.42

-1.745 (-1.23%)

17:06
11/04/19
11/04
17:06
11/04/19
17:06

Steris sees FY20 EPS $5.50 - $5.65, consensus $5.47

Based on current performance and expectations for the full fiscal year, the Company is updating its prior outlook for revenue and adjusted earnings per diluted share. Constant currency organic revenue growth is now expected to be in the range of 7.5-8.5%, compared with 6-7% previously. The increase in constant currency organic revenue growth is due to outperformance of the underlying business as well as approximately one percentage point benefit from a number of tuck-in acquisitions completed in the first half of the year. Reflecting September 30, 2019 forward rates, the Company now expects that currency movements will negatively impact as reported revenue by approximately $25 million in fiscal 2020. Adjusted earnings per diluted share are now anticipated to be in the range of $5.50 - $5.65, compared with $5.38 - $5.53 previously. Consensus for FY20 revenue is $2.96B.

  • 05

    Nov

  • 13

    Nov

  • 03

    Dec

STE Steris
$140.42

-1.745 (-1.23%)

11/13/18
KEYB
11/13/18
NO CHANGE
Target $132
KEYB
Overweight
STERIS price target raised to $132 from $120 at KeyBanc
KeyBanc analyst Matthew Mishan raised his price target for STERIS to $132 from $120 post Q2. Moving forward, the analyst continues to believe that there are drivers to sustain long-term organic revenue growth at over 5%, it seems capable of offsetting various cost headwinds and there is opportunity for steady operating margin expansion, and eventually, there could be upside to estimates from EPS accretive M&A. Mishan reiterates an Overweight rating on the shares.
05/15/19
SPHN
05/15/19
NO CHANGE
Target $150
SPHN
Overweight
STERIS price target raised to $150 from $135 at Stephens
Stephens analyst Chris Cooley raised his price target on STERIS shares to $150 from $135 after the company reported Q4 results that topped consensus, noting that all four of the its business segments had better than expected revenue growth and increased operating margins. Cooley, who said he is confident STERIS can either meet or exceed its FY20 guidance, keeps an Overweight rating on the shares, which he continues to view as a "core holding."
07/09/19
KEYB
07/09/19
DOWNGRADE
KEYB
Sector Weight
STERIS downgraded to Sector Weight from Overweight at KeyBanc
07/10/19
KEYB
07/10/19
DOWNGRADE
KEYB
Sector Weight
Steris downgraded to Sector Weight on valuation at KeyBanc
KeyBanc analyst Matthew Mishan last night downgraded Steris to Sector Weight from Overweight with the shares above his previous price target of $138. The stock, after rallying 43% year-to-date, could be reaching its "vertical limit," Mishan tells investors in a research note. With that said, the analyst remains confident in a "sustained runway for organic growth" for Steris.

TODAY'S FREE FLY STORIES

UPS

UPS

$116.87

-0.67 (-0.57%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Hot Stocks
UPS reports expansion of UPS Worldwide Express, Express Plus across 40 countries »

UPS announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$60.30

-0.69 (-1.13%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Options
Centene put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

CNST

Constellation Pharmaceuticals

$47.50

3.4 (7.71%)

10:14
12/09/19
12/09
10:14
12/09/19
10:14
Hot Stocks
Breaking Hot Stocks news story on Constellation Pharmaceuticals »

Constellation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

ACHN

Achillion

$6.19

0.02 (0.32%)

10:14
12/09/19
12/09
10:14
12/09/19
10:14
Hot Stocks
Achillion reports 'positive' data from Phase 2 danicopan, eculizumab study »

Achillion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

ATRA

Atara Biotherapeutics

$14.24

0.25 (1.79%)

10:12
12/09/19
12/09
10:12
12/09/19
10:12
Hot Stocks
Atara reports updated long-term clinical results from Tab-cel EBV+ PTLD study »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOB

Globant

$102.78

-0.525 (-0.51%)

10:12
12/09/19
12/09
10:12
12/09/19
10:12
Conference/Events
Globant management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

  • 16

    Jan

CNST

Constellation Pharmaceuticals

$47.50

3.4 (7.71%)

10:12
12/09/19
12/09
10:12
12/09/19
10:12
Hot Stocks
Constellation Pharmaceuticals provides update on MANIFEST clinical trial »

Constellation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

DTIL

Precision BioSciences

$18.00

-1.66 (-8.44%)

10:11
12/09/19
12/09
10:11
12/09/19
10:11
Hot Stocks
Breaking Hot Stocks news story on Precision BioSciences »

Precision BioSciences Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

MTEM

Molecular Templates

$12.23

(0.00%)

10:10
12/09/19
12/09
10:10
12/09/19
10:10
Hot Stocks
Molecular Templates announces presentations of two posters at ASH »

Molecular Templates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$31.72

0.545 (1.75%)

10:10
12/09/19
12/09
10:10
12/09/19
10:10
Conference/Events
Avis Budget management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

XNCR

Xencor

$41.27

0.25 (0.61%)

10:08
12/09/19
12/09
10:08
12/09/19
10:08
Hot Stocks
Xencor presents Initial Data from Phase 1 Study of XmAb 13676 »

Xencor announced initial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

SGEN

Seattle Genetics

$117.12

-0.4 (-0.34%)

, TAK

Takeda Pharmaceutical

$20.12

-0.15 (-0.74%)

10:08
12/09/19
12/09
10:08
12/09/19
10:08
Hot Stocks
Seattle Genetics, Takeda announce additional analyses of Adcetris »

Seattle Genetics (SGEN)…

SGEN

Seattle Genetics

$117.12

-0.4 (-0.34%)

TAK

Takeda Pharmaceutical

$20.12

-0.15 (-0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

DTIL

Precision BioSciences

$19.88

0.22 (1.12%)

10:06
12/09/19
12/09
10:06
12/09/19
10:06
Hot Stocks
Breaking Hot Stocks news story on Precision BioSciences »

Precision BioSciences Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

ARMK

Aramark

$42.70

-0.32 (-0.74%)

10:06
12/09/19
12/09
10:06
12/09/19
10:06
Conference/Events
Aramark management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

INTC

Intel

$56.80

(0.00%)

10:04
12/09/19
12/09
10:04
12/09/19
10:04
Hot Stocks
Intel reveals what it believes to be a first-of-its-kind cryogenic control chip »

Intel Labs unveiled what…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 23

    Jan

CNST

Constellation Pharmaceuticals

$48.50

4.4 (9.98%)

10:04
12/09/19
12/09
10:04
12/09/19
10:04
Hot Stocks
Breaking Hot Stocks news story on Constellation Pharmaceuticals »

Constellation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

10:01
12/09/19
12/09
10:01
12/09/19
10:01
Conference/Events
JPMorgan media analyst to hold an analyst/industry conference call »

Media Analyst Quadrani…

CHWY

Chewy

$24.75

-0.18 (-0.72%)

10:00
12/09/19
12/09
10:00
12/09/19
10:00
Options
Notable put buying in Chewy ahead of earnings »

Notable put buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

SSI

Stage Stores

$6.30

0.695 (12.40%)

10:00
12/09/19
12/09
10:00
12/09/19
10:00
Hot Stocks
Stage Stores rises 11.5% »

Stage Stores is up 11.5%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$11.16

1.51 (15.65%)

10:00
12/09/19
12/09
10:00
12/09/19
10:00
Hot Stocks
PG&E rises 15.8% »

PG&E is up 15.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$182.40

26.61 (17.08%)

10:00
12/09/19
12/09
10:00
12/09/19
10:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN rises 17.0% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:58
12/09/19
12/09
09:58
12/09/19
09:58
Conference/Events
JPMorgan oil services/equip analyst to hold an analyst/industry conference call »

Oil Services &…

PCG

PG&E

$11.30

1.65 (17.10%)

, SIG

Signet Jewelers

$21.05

0.48 (2.33%)

09:55
12/09/19
12/09
09:55
12/09/19
09:55
Options
Early notable gainers among liquid option names on December 9th »

Notable gainers among…

PCG

PG&E

$11.30

1.65 (17.10%)

SIG

Signet Jewelers

$21.05

0.48 (2.33%)

SWKS

Skyworks

$104.20

2.8 (2.76%)

FCX

Freeport McMoRan

$11.97

0.33 (2.84%)

FTV

Fortive

$75.51

2.65 (3.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 07

    Jan

09:55
12/09/19
12/09
09:55
12/09/19
09:55
Conference/Events
JPMorgan homebuilding analyst to hold an analyst/industry conference call »

Homebuilding &…

09:55
12/09/19
12/09
09:55
12/09/19
09:55
Conference/Events
JPMorgan business services analyst to hold analyst/industry conference call »

Business &…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.